Chemed (NYSE:CHE) Stock Price Down 4.9% – Time to Sell?

Chemed Corporation (NYSE:CHE)’s stock price fell 4.9% during trading on Thursday . The company traded as low as $519.51 and last traded at $521.5150. 131,404 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 214,262 shares. The stock had previously closed at $548.56.

Analysts Set New Price Targets

Several research firms recently issued reports on CHE. Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Finally, Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $530.75.

Chemed Stock Performance

The firm has a market cap of $6.84 billion, a P/E ratio of 26.30, a PEG ratio of 1.97 and a beta of 0.51. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. The company’s 50-day moving average is $509.45 and its two-hundred day moving average is $449.67.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same period in the prior year, the business posted $4.27 earnings per share. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed’s dividend payout ratio is 14.06%.

Insiders Place Their Bets

In other Chemed news, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Spencer S. Lee sold 1,000 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.04, for a total value of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares of the company’s stock, valued at $7,526,948.48. This trade represents a 6.71% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 6,537 shares of company stock worth $3,406,014 in the last ninety days. Company insiders own 3.33% of the company’s stock.

Institutional Trading of Chemed

A number of large investors have recently added to or reduced their stakes in the stock. Monetary Solutions Ltd bought a new position in shares of Chemed during the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC purchased a new stake in shares of Chemed during the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. purchased a new position in Chemed in the fourth quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Chemed in the second quarter valued at approximately $34,000. Finally, Versant Capital Management Inc grew its holdings in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after purchasing an additional 75 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.